Adding new covalent bonds to proteins in live cells
Adding new covalent bonds to proteins in live cells
批准号:
10651718
负责人:
Lei Wang
金额:
$35.08万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-20 至 2024-06-30
关键词:
Alzheimer&aposs DiseaseAmino AcidsBindingBinding ProteinsBiologicalBiological ProcessBiological Response Modifier TherapyBiologyBiotechnologyCarbohydratesCell CommunicationCellsChemicalsChemistryClustered Regularly Interspaced Short Palindromic RepeatsDataDimensionsDiseaseEngineeringEnzymesExcisionFamilyFoundationsGenerationsGenetic CodeGlucosamineGlycoproteinsGoalsHumanIn SituIn VitroLightLinkMammalian CellMendelian disorderMethodsModificationMolecularNatureNon-Insulin-Dependent Diabetes MellitusOpticsOrganismPhysiologicalProtein BiosynthesisProtein EngineeringProtein-Carbohydrate InteractionProteinsRNARNA BindingRNA ProbesRNA-Binding ProteinsRNA-Protein InteractionReactionResearchResearch PersonnelSideSiteSpecificitySystemTechniquesTechnologyTimeUltraviolet Raysbiological researchbiomaterial compatibilitycancer cellcancer typechemical synthesiscovalent bondcrosslinkdesigndisulfide bonddrug developmentglycosylationhuman diseasein vivoinhibitorinnovationnanonew technologynovelpeptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidaseprotein protein interactionsuccesstoolunnatural amino acids
中文摘要
项目概要/摘要
蛋白质通过与不同家族的双分子相互作用来执行各种生物学功能。这些
相互作用本质上主要是非共价的。尽管这种非共价相互作用提供了多样性和
生物学的动力学,其可逆性和弱点也对研究和
工程化蛋白质-双分子相互作用。在这种应用中,通过设计,
并将生物活性非天然氨基酸(Uaas)基因整合到蛋白质中,这将使蛋白质
以共价方式与核糖核酸和碳水化合物结合。潜在的创新是开发
生物相容性化学,使得Uaa将选择性地与靶核糖核酸或碳水化合物反应
通过仅在结合时的邻近使能反应性,导致蛋白质之间的稳定和不可逆的连接,
和目标为了实现这些目标,适合于共价靶向核糖核酸的新化学物质和
将开发细胞和生理条件下的碳水化合物。所需的化学官能度将
被合成到Uaa的侧链中,并且Uaa将被位点特异性地掺入蛋白质中,
通过基因密码扩展技术获得活细胞。这种新的共价键合策略将应用于现场
细胞了解RNA-蛋白质识别特异性,识别糖基化底物糖蛋白
修饰酶,并拮抗细胞-细胞通讯。通过利用新的共价键
天然蛋白质无法获得,该项目将开创一个新的研究领域,
工程化蛋白质-RNA和蛋白质-碳水化合物相互作用。因为这种互动是必不可少的,
生物学功能及其畸变广泛涉及各种人类疾病,新的
该项目产生的技术将从根本上影响基础生物学研究和治疗
应用.
英文摘要
Project Summary/Abstract
Proteins perform a variety of biological functions by interacting with different families of bimolecules. These
interactions are largely noncovalent in nature. Although such noncovalent interactions provide diversity and
dynamics for biology, their reversibility and weakness also impose strong limitations on researching and
engineering protein-bimolecule interactions. In this application the natural barrier will be broken by designing
and genetically incorporating bioreactive unnatural amino acids (Uaas) into proteins, which will enable proteins
to bind with ribonucleic acids and carbohydrates in the covalent mode. The underlying innovation is to develop
biocompatible chemistry, so that the Uaa will selectively react with the target ribonucleic acid or carbohydrate
via proximity-enabled reactivity only upon binding, resulting in stable and irreversible linkage between protein
and the target. To achieve these goals, new chemistries suitable for covalently targeting ribonucleic acids and
carbohydrates in cellular and physiological conditions will be developed. The desired chemical functionality will
be synthesized into the side chain of a Uaa, and the Uaa will be site-specifically incorporated into proteins in
live cells via the genetic code expansion technology. This new covalent bonding strategy will be applied in live
cells to understand RNA-protein recognition specificity, to identify substrate glycoproteins for glycosylation
modifying enzymes, and to antagonize cell-cell communication. By harnessing the new covalent linkages
inaccessible to natural proteins, this project will initiate a new dimension for researching and rationally
engineering protein-RNA and protein-carbohydrate interactions. As such interactions are indispensable for
biological functions and their aberrations are extensively implicated in various human diseases, new
technologies resulting from this project will fundamentally impact both basic biological research and therapeutic
applications.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/cbic.202100218
发表时间:
2021-08-03
期刊:
Chembiochem : a European journal of chemical biology
影响因子:
--
作者:
[Cao L, Liu J, Ghelichkhani F, Rozovsky S, Wang L]
通讯作者:
Wang L
DOI:
10.1021/jacs.8b05814
发表时间:
2018-09-05
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Fu C, Kobayashi T, Wang N, Hoppmann C, Yang B, Irannejad R, Wang L]
通讯作者:
Wang L
DOI:
10.1021/jacs.8b04603
发表时间:
2018-07-18
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Liu J, Zheng F, Cheng R, Li S, Rozovsky S, Wang Q, Wang L]
通讯作者:
Wang L
Residue selective crosslinking of proteins through photoactivatable or proximity-enabled reactivity.
DOI:
10.1016/j.cbpa.2023.102285
发表时间:
2023-03
期刊:
Current opinion in chemical biology
影响因子:
7.8
作者:
[Jun Liu;Bin Yang;Lei Wang]
通讯作者:
Jun Liu;Bin Yang;Lei Wang
DOI:
10.1021/jacs.0c06820
发表时间:
2020-10-07
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Liu J, Cheng R, Van Eps N, Wang N, Morizumi T, Ou WL, Klauser PC, Rozovsky S, Ernst OP, Wang L]
通讯作者:
Wang L
共 15 条
Covalent Protein Binders for Cancer Research and Therapy
-
批准号:10360531
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2021
-
负责人:Lei Wang
-
依托单位:
Covalent Protein Binders for Cancer Research and Therapy
-
批准号:10179199
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2021
-
负责人:Lei Wang
-
依托单位:
Covalent Protein Binders for Cancer Research and Therapy
-
批准号:10569518
-
项目类别:
-
资助金额:$39.61万
-
财政年份:2021
-
负责人:Lei Wang
-
依托单位:
TERBO BRAIN Study: Trajectories of Emotional Regulation and Behavior Outcomes and related Brain Regions And Intrinsic Networks
-
批准号:10663934
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
TERBO BRAIN Study: Trajectories of Emotional Regulation and Behavior Outcomes and related Brain Regions And Intrinsic Networks
-
批准号:10065446
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice
-
批准号:10121320
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
TERBO BRAIN Study: Trajectories of Emotional Regulation and Behavior Outcomes and related Brain Regions And Intrinsic Networks
-
批准号:10264955
-
项目类别:
-
资助金额:$43.03万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice
-
批准号:10413254
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice
-
批准号:10643939
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice
-
批准号:10262969
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Macula densa NOS1 and transplanted renal graft function
-
批准号:10609888
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Macula densa NOS1 and transplanted renal graft function
-
批准号:10380831
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Macula densa NOS1 and transplanted renal graft function
-
批准号:9973527
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2020
-
负责人:Lei Wang
-
依托单位:
Nano-switches for optogenetic control of neuronal proteins with ultra-specificity
-
批准号:9379982
-
项目类别:
-
资助金额:$175.18万
-
财政年份:2017
-
负责人:Lei Wang
-
依托单位:
Adding new covalent bonds to proteins in live cells
-
批准号:10264120
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2016
-
负责人:Lei Wang
-
依托单位:
Adding new covalent bonds to proteins in live cells
-
批准号:10119770
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2016
-
负责人:Lei Wang
-
依托单位:
Adding New Covalent Bonds to Proteins in Live Cells
-
批准号:9264558
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2016
-
负责人:Lei Wang
-
依托单位:
Adding new covalent bonds to proteins in live cells
-
批准号:10442720
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2016
-
负责人:Lei Wang
-
依托单位:
Thymosin Beta 4 Promotes Recovery of Peripheral Neuropathy in Diabetic Mice
-
批准号:8421251
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2013
-
负责人:Lei Wang
-
依托单位:
Thymosin Beta4 Promotes the Recovery of Peripheral neuropathy in Type II Diabetic
-
批准号:8841342
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2013
-
负责人:Lei Wang
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: